EUVIMEDEUVIMED entdecken
Open Access

Exploration of anti‑osteosarcoma activity of asiatic acid based on network pharmacology and in vitro experiments

He Pang, Hang Wu, Zeyu Zhan, Tingrui Wu, Min Xiang, Zhiyan Wang, Lijun Song, Bo Wei

Oncology Reports · 28.12.2023 · 51 (2)

DOI: 10.3892/or.2023.8692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, online erschienen am 28.12.2023. Verfasst von He Pang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Orthopedics Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, P.R. China. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcomas are malignant bone tumors that typically originate in the epiphyses of the long bones of the extremities in adolescents. Asiatic acid has been reported to possess anti‑inflammatory, neuroprotective, antidiabetic, antitumor and antimicrobial activities. The present study used a combination of network pharmacological prediction and in vitro experimental validation to explore the potential pharmacological mechanism of asiatic acid against osteosarcoma. A total of 78 potential asiatic acid targets in osteosarcoma were identified using databases. Kyoto Encyclopedia of Genes and Genomes analysis indicated that the PI3K/AKT and MAPK signaling pathways are essential in the treatment of osteosarcoma with asiatic acid. Molecular docking revealed binding of asiatic acid to EGFR, Caspase‑3, ESR1, HSP90AA1, IL‑6 and SRC proteins. asiatic acid inhibited proliferation through G2/M cell cycle arrest in osteosarcoma cells. In addition, asiatic acid induced mitochondria‑dependent apoptosis as demonstrated by increases in Bax and VDAC1 expression, and a decrease in Bcl‑2 protein expression. The increased autophagosomes, increased LC3‑II/I ratios and decreased p62 expression in the treatment group indicated that asiatic acid triggered autophagy. In addition, asiatic acid decreased the levels of phosphorylated (p‑)PI3K/PI3K and p‑AKT/AKT, increased reactive oxygen species (ROS) and upregulated the levels of p‑ERK1/2/ERK1/2, p‑p38/p38 and p‑JNK/JNK in osteosarcoma cells. These results demonstrated that asiatic acid inhibited osteosarcoma cells proliferation by inhibiting PI3K/AKT and activating ROS/MAPK signaling pathways, suggesting asiatic acid is a potential agent against osteosarcoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaBone NeoplasmsHumansAdolescentMolecular Docking SimulationNetwork PharmacologyPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen SpeciesPentacyclic Triterpenes

Stichwörter der Autor:innen

apoptosisasiatic acidautophagycell cycleosteosarcoma

Substanzen

Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen Speciesasiatic acidPentacyclic Triterpenes

Autor:innen und Institutionen

  • Orthopedics Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, P.R. China.
  • Guangdong Medical University, Zhanjiang, Guangdong 524001, P.R. China.
  • Reproductive Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, P.R. China.

Zitieren

APA

Pang, H., Wu, H., Zhan, Z., Wu, T., Xiang, M., Wang, Z., Song, L., & Wei, B. (2023). Exploration of anti‑osteosarcoma activity of asiatic acid based on network pharmacology and in vitro experiments. Oncology Reports, 51(2). https://doi.org/10.3892/or.2023.8692

Vancouver

Pang H, Wu H, Zhan Z, Wu T, Xiang M, Wang Z, et al. Exploration of anti‑osteosarcoma activity of asiatic acid based on network pharmacology and in vitro experiments. Oncology Reports. 2023;51(2). doi:10.3892/or.2023.8692

BibTeX
@article{Pang2023,
  author = {Pang, He and Wu, Hang and Zhan, Zeyu and Wu, Tingrui and Xiang, Min and Wang, Zhiyan and Song, Lijun and Wei, Bo},
  title = {Exploration of anti‑osteosarcoma activity of asiatic acid based on network pharmacology and in vitro experiments},
  journal = {Oncology Reports},
  year = {2023},
  volume = {51},
  number = {2},
  doi = {10.3892/or.2023.8692}
}
Kostenlos starten →